234 results
Page 3 of 12
8-K
EX-99.1
g8gc28kw2jerzb4e c6e
14 Jun 21
Cassava Sciences Announces the Appointment of
4:14pm
8-K
EX-10.1
ieg4hlvd8a59bgl hhm
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
8-K
EX-99.1
mcjlr8
11 Mar 21
Cassava Sciences Announces Pharmaceutical Supply Agreement for Simufilam
4:59pm
8-K
EX-10.1
tikzujj1ho gzy6
12 Feb 21
Cassava Sciences Announces $200 Million Registered Direct Offering of Common Stock
5:09pm
424B5
vw7yjkbhzq1
12 Feb 21
Prospectus supplement for primary offering
12:00am
S-3ASR
2berr5jjyg4r6
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
EX-4.5
bnhvr3e
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
EX-4.6
et6u v5x4tun
10 Feb 21
Automatic shelf registration
6:04am
S-3ASR
EX-5.1
2uzr8fc
10 Feb 21
Automatic shelf registration
6:04am
8-K
EX-99.2
w2fscal7mkj
8 Feb 21
Regulation FD Disclosure
4:09pm
8-K
EX-3.1
1v0cb61o6io 6hczbx6q
11 Dec 20
Amendments to Articles of Incorporation or Bylaws
4:43pm
424B5
zpnwg l32lu2850qv0
16 Nov 20
Prospectus supplement for primary offering
12:21pm
8-K
EX-1.1
wuj 00721gws2vzw
13 Nov 20
Cassava Sciences Announces Proposed Public Offering of Common Stock
4:36pm
424B5
eh6 9v1gktvtkwlrbi
12 Nov 20
Prospectus supplement for primary offering
4:57pm